Skip to main content

JPMORGAN CHASE & CO

Position in GRFS — Grifols SA

CIK 19617 NEW YORK, NY

Position in GRFS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$21,666,605
+$569,643 QoQ
Shares Held
2,701,572
+19.7% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.92193434045066.ToString("F0")% Shared 0.ToString("F0")% None 0.07806565954932905.ToString("F0")%

Common Shares in GRFS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $65,165,946,852 across 18 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRFS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,666,605 2,701,572
2025-12-31 $21,096,962 2,256,360
2025-09-30 $24,783,405 2,488,294
2025-06-30 $17,069,106 1,888,176
2025-03-31 $11,862,690 1,668,452
2024-12-31 $14,791,036 1,988,043
2024-09-30 $17,782,294 2,002,511
2024-06-30 $5,177,679 820,552
2024-03-31 $7,029,194 1,052,275
2023-12-31 $21,892,082 1,893,779
2023-09-30 $12,509,156 1,368,617
2023-06-30 $9,519,481 1,039,245
2023-03-31 $14,176,199 1,923,501
2022-12-31 $13,435,005 1,580,589
2022-09-30 $15,871,188 2,576,492
2022-06-30 $36,874,151 3,103,885
2022-03-31 $37,421,723 3,203,915
2021-12-31 $36,824,683 3,279,135
2021-09-30 $52,760,872 3,611,285
2021-06-30 $40,670,530 2,344,123
2021-03-31 $37,182,176 2,150,502
2020-12-31 $25,452,821 1,380,305
2020-09-30 $20,816,510 1,199,799
2020-06-30 $4,322,166 236,961
2020-03-31 $13,303,493 660,551